About the benefits of immunotherapy for high-risk neuroblastoma

J Clin Oncol. 2013 Feb 10;31(5):649-50. doi: 10.1200/JCO.2012.47.4080. Epub 2013 Jan 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage*
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Isotretinoin / administration & dosage*
  • Male
  • Neuroblastoma / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Isotretinoin